Ambria Capital

About The Fund

Ambria Capital is an investment fund that targets early-stage companies operating within the Biotech, HealthTech, Blockchain, Web Security, Medical Devices, Healthcare, Consumer, and Pharmaceutical industries. Specializing in Seed, Series A, and Pre-seed stages, Ambria Capital is committed to empowering startups that strive to make significant impacts on markets and improve millions of lives, with a particular focus on mental health and technology spaces. They invest their own capital and can remain invested for as long as necessary, highlighting their flexibility. Ambria Capital is willing to welcome the risks associated with early-stage investments, understanding that while there is uncertainty, there is also the potential for great, life-changing investments. The fund upholds true belief in their chosen ventures, committing to their mission and purpose from the outset. Ambria Capital's dedication is to real impact, assisting companies that catalyze change and provide meaningful improvements in people's lives. They focus on asymmetric bets, championing companies that tackle the most pressing issues of the generation. One distinct area of focus is the psychedelic industry, where they see an opportunity to revolutionize mental healthcare with the promising scientific evidence of psychedelics in clinical trials. The fund's 'sweet spot' for investments is around $1,500,000, with a minimum investment threshold of $100,000 and a maximum investment limit of $5,000,000. Ambria Capital thus aims to enable visionary entrepreneurs to fulfill the promise held by their novel solutions in these challenging yet crucial sectors.